XML 39 R25.htm IDEA: XBRL DOCUMENT v3.6.0.2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2016
Change in Accounting Estimate [Line Items]  
Schedule of Fair Value of Financial Instruments
The following are measured at fair value:
 
 
 
Fair value measurement at December 31, 2016
 
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(In millions)
Money market funds
$
328.5

 
$
328.5

 
$

 
$

 
 
 
Fair value measurement at December 31, 2015
 
Total
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
(In millions)
Money market funds
$
141.8

 
$
141.8

 
$

 
$

Summary of Cash and Cash Equivalents and Grantor Trust by Investment Type
As of December 31, 2016, a summary of cash and cash equivalents and the grantor trust by investment type was as follows:
 
Total
 
Cash and
Cash Equivalents
 
Money Market
Funds
 
(In millions)
Cash and cash equivalents
$
410.3

 
$
89.8

 
$
320.5

Grantor trust (included as a component of other current and noncurrent assets)
8.0

 

 
8.0

 
$
418.3

 
$
89.8

 
$
328.5

Schedule of Estimated Fair Value and Principal Amount of Outstanding Debt
The following table summarizes the estimated fair value and principal amount for outstanding debt obligations:
 
Fair Value
 
Principal Amount
 
December 31, 2016
 
December 31, 2015
 
December 31, 2016
 
December 31, 2015
 
(In millions)
Term loan
$
390.0

 
$
92.5

 
$
390.0

 
$
92.5

7.125% Second-Priority Senior Secured Notes (“7 1/8% Notes”)

 
479.6

 

 
460.0

2.25% Convertible Senior Notes ("2 1/4% Notes")
294.9

 

 
300.0

 

4 1/16% Convertible Subordinated Debentures (“4 1/16% Debentures”) (1)
70.8

 
149.5

 
35.6

 
84.6

Delayed draw term loan

 
13.0

 

 
13.0

Other debt

 
0.6

 

 
0.5

 
$
755.7

 
$
735.2

 
$
725.6

 
$
650.6


_______
(1)
In December 2016, the Company notified holders of its 4 1/16% Debentures that the Company would redeem, on February 3, 2017, all of their 4 1/16% Debentures at a purchase price equal to 100% of the principal amount of the 4 1/16% Debentures to be redeemed, plus any accrued and unpaid interest. In January 2017, $35.6 million of the 4 1/16% Debentures (the entire amount outstanding as of December 31, 2016) were converted to 3.9 million shares of common stock.
Schedule of Useful Lives of Property, Plant and Equipment
Depreciation is computed principally by accelerated methods based on the following useful lives:  
Buildings and improvements
9 - 40  years
Machinery and equipment
5 - 19  years
Schedule of Changes in Carrying Amount of Conditional Asset Retirement Obligations
The changes in the carrying amount of CAROs since November 30, 2013 were as follows (in millions):
Balance as of November 30, 2013
$
22.9

Additions and other, net
(0.2
)
Accretion
1.7

Balance as of November 30, 2014
24.4

Additions and other, net
3.0

Accretion
1.9

Balance as of November 30, 2015
29.3

Accretion
0.2

Balance as of December 31, 2015
29.5

Additions and other, net
(0.9
)
Accretion
2.0

Balance as of December 31, 2016
$
30.6

AR1 Inception to Date Project Costs
The AR1 inception to date project costs were as follows (in millions):
AR1 R&D costs incurred
$
169.3

Less amounts funded by the U.S. Air Force
(92.9
)
Less amounts funded by ULA
(5.0
)
AR1 R&D costs net of reimbursements
71.4

AR1 R&D costs expensed and not applied to contracts
(32.1
)
Net AR1 R&D costs applied to contracts
$
39.3

Schedule of Sales to U.S. Government and its Agencies
Sales to the U.S. government and its agencies, including sales to the Company’s significant customers discussed below, were as follows:
 
Percentage of Net
Sales
Fiscal 2016
91
%
Fiscal 2015
90
%
Fiscal 2014
92
%
One month ended December 31, 2015
85
%
Schedule of Customers that Represented More than 10% of Net Sales
Customers that represented more than 10% of net sales for the periods presented were as follows:
 
Year Ended
 
One month ended
 
December 31,
 
November 30,
 
November 30,
 
December 31,
 
2016
 
2015
 
2014
 
2015
Lockheed Martin Corporation ("Lockheed Martin")
27
%
 
29
%
 
28
%
 
24
%
ULA
21

 
19

 
25

 
28

Raytheon Company ("Raytheon")
20

 
20

 
17

 
19

NASA
13

 
11

 
11

 
10

Schedule of Customers that Represented More than 10% of Accounts Receivable
Customers that represented more than 10% of accounts receivable for the periods presented were as follows:
 
 
As of December 31,
 
2016
 
2015
 
 
 
 
ULA
20
%
 
14
%
Lockheed Martin
17

 
16

Raytheon
17

 
19

NASA
14

 
*

The Boeing Company ("Boeing")
13

 
24

_____
* Less than 10%
Contracts Accounted for under Percentage-of-Completion [Member]  
Change in Accounting Estimate [Line Items]  
Summary of Impact of Contracts in Progress on Statement of Operations
The following table summarizes the impact from changes in estimates and assumptions on the statements of operations on contracts, representing 94% of the Company’s aerospace and defense segment net sales over the last three fiscal years and one month ended December 31, 2015, accounted for under the percentage-of-completion method of accounting:
 
Year Ended
 
One month ended
 
December 31,
 
November 30,
 
November 30,
 
December 31,
 
2016
 
2015
 
2014
 
2015
 
(In millions, except per share amounts)
Favorable effect of the changes in contract estimates on income (loss) from continuing operations before income taxes
$
14.1

 
$
41.2

 
$
9.2

 
$
11.7

Favorable effect of the changes in contract estimates on net income (loss)
8.5

 
24.7

 
5.5

 
7.0

Favorable effect of the changes in contract estimates on basic net income (loss) per share
0.13

 
0.40

 
0.10

 
0.11

Favorable effect of the changes in contract estimates on diluted net income (loss) per share
0.11

 
0.40

 
0.10

 
0.09